2-(4-苯磺酰氯)嘧啶 | 912569-53-0

• 物质功能分类: 医药中间体 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-苯磺酰氯)嘧啶
• 中文别名: 4-嘧啶基-2-苯磺酰氯
• 英文名称: 4-pyrimidin-2-ylbenzenesulfonyl chloride
• 英文别名: 4-(Pyrimidin-2-yl)benzene-1-sulfonyl chloride
• CAS: 912569-53-0
• 化学式: C₁₀H₇ClN₂O₂S
• mdl: MFCD09817488
• 分子量: 254.697
• InChiKey: BPLYUKDYQDTCTE-UHFFFAOYSA-N

物化性质

• 熔点：
  159.5-161.5
• 沸点：
  310.7±34.0 °C(Predicted)
• 密度：
  1.432±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2933599090

反应信息

• 作为反应物：
  描述：

  2-(4-苯磺酰氯)嘧啶 、 (1S,5S,6R)-3-(pyridin-2-ylmethyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one 在 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以50%的产率得到(1S,5S,6R)-3-(pyridin-2-ylmethyl)-10-((4-(pyrimidin-2-yl)phenyl)sulfonyl)-5-vinyl-3,10-diazabicyclo[4.3.1]decan-2-one
  参考文献：
  名称：

  Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins

  摘要：

  FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl isomerase activities and act as coreceptors for immunosuppressants. Microbial macrophage-infectivity-potentiator (Mip)-type FKBPs can enhance infectivity. However, developing druglike ligands for FKBPs or Mips has proven difficult, and many FKBPs and Mips still lack biologically useful ligands. To explore the scope and potential of C5-substituted [4.3.1]-azabicyclic sulfonamides as a broadly applicable class of FKBP inhibitors, we developed a new synthesis method for the bicyclic core scaffold and used it to prepare an FKBP- and Mip-focused library. This allowed us to perform a systematic structure activityrelationship analysis across key human FKBPs and microbial Mips, yielding highly improved inhibitors for all the FKBPs studied. A cocrystal structure confirmed the molecular-binding mode of the core structure and explained the affinity gained as a result of the preferred substituents. The best FKBP and Mip ligands showed promising antimalarial, antileginonellal, and antichlamydial properties in cellular models of infectivity, suggesting that substituted [4.3.1]-aza-bicyclic sulfonamides could be a novel class of anti-infectives.

  DOI：

  10.1021/acs.jmedchem.8b00137

文献信息

• BENZOCYCLOHEPTENE ACETIC ACIDS
  申请人：Firooznia Fariborz

  公开号：US20120309796A1

  公开（公告）日：2012-12-06

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD.

  本文提供的是化合物的公式(I)以及其药用盐，其中取代基如规范中所披露的那样。这些化合物及含有它们的药物组合物对于治疗炎症性疾病和紊乱，如哮喘和慢性阻塞性肺病等，具有用处。
• [EN] PIPECOLATE-SULFONAMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS<br/>[FR] PIPÉCOLATE-SULFONAMIDES POUR LE TRAITEMENT DE TROUBLES PSYCHIATRIQUES
  申请人：MAX PLANCK GESELLSCHAFT

  公开号：WO2013097947A1

  公开（公告）日：2013-07-04

  The present invention relates to compounds having a pipecolate sulfonamide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said pipecolate sulfonamide compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.

  本发明涉及具有吡哌酸磺胺基骨架的化合物，这些化合物的药用盐以及含有至少一种这些化合物的药用载体、赋形剂和/或稀释剂的药物组合物。所述的吡哌酸磺胺基化合物可用于预防和/或治疗精神障碍和神经退行性疾病、紊乱和状况。
• Pipecolate-sulfonamides for treatment of psychiatric disorders
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP2610245A1

  公开（公告）日：2013-07-03

  The present invention relates to compounds having a pipecolate sulfonamide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said pipecolate sulfonamide compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.

  本发明涉及具有吡啶甲酸磺酰胺骨架的化合物，这些化合物的药用盐以及含有至少一种这些化合物的药用载体、赋形剂和/或稀释剂的药物组合物。所述的吡啶甲酸磺酰胺化合物可用于预防和/或治疗精神障碍和神经退行性疾病、障碍和症状。
• [EN] HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE<br/>[FR] HÉTÉROARYL BENZAMIDES, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
  申请人：UNIV LELAND STANFORD JUNIOR

  公开号：WO2011011514A1

  公开（公告）日：2011-01-27

  Provided are certain heteroaryl benzamides, compositions, and methods of their manufacture and use.

  提供了某些杂环芳酰苯胺、组合物及其制备和使用方法。
• HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE
  申请人：Sutphin Patrick D.

  公开号：US20120225862A1

  公开（公告）日：2012-09-06

  Provided are certain heteroaryl benzamides, compositions, and methods of their manufacture and use.

  提供了某些杂环芳酰苯胺、组成物及其制造和使用方法。